大学职业搜题刷题APP
下载APP
首页
课程
题库模板
Word题库模板
Excel题库模板
PDF题库模板
医考护考模板
答案在末尾模板
答案分章节末尾模板
题库创建教程
创建题库
登录
logo - 刷刷题
创建自己的小题库
搜索
【简答题】

Exactly where we will stand in the long war against disease by the year 2050 is impossible to say. (61) But if developments in research maintain their current pace, it seems likely that a combination of improved attention to dietary and environmental factors, along with advances in gene therapy and protein targeted drugs, will have virtually eliminated most major classes of disease.
From an economic standpoint, the best news may be that these accomplishments could be accompanied by a drop in health-care costs. (62) Costs may even fall as diseases are brought under control using pinpointed, short term therapies now being developed. By 2050 there will be fewer hospitals, and surgical procedures will be largely restricted to the treat ment of accidents and other forms of trauma(外伤). Spending on nonacute(慢性病的) care, both in nursing facilities and in homes, will also fall sharply as more elderly people lead healthy lives until close to death.
One result of medicine’s success in controlling disease will be a dramatic increase in life expectancy. (63) The extent of that increase is a highly speculative matter, but it is worth noting that medical science has already helped to make the very old (currently defined as those over 85 years of age) the fastest growing segment of the population. Between 1960 and 1995, the U.S. population as a whole increased by about 45%, while the segment over 85 years of age grew by almost 300%. () There has been a similar explosion in the population of centenarians, with the result that survival to the age of 100 is no longer the newsworthy feat that it was only a few decades ago. U.S. Census Bureau projections already forecast dramatic increase in the number of centenarians in the next 50 years: 4 million in 2050, compared with 37,000 in 1990.
(65) Although Census Bureau calculations project an increase in average life span of only eight years by the year 2050, some experts believe that the human life span should not begin to encounter any theoretical natural limits before 120 years.With continuing advances in molecular medicine and a growing understanding of the aging process, that limit could rise to 130 years or more.

Costs may even fall as diseases are brought under control using pinpointed, short term therapies now being developed.

Exactly where we will stand in the long war against disease by the year 2050 is impossible to say. (61) But if developments in research maintain their current pace, it seems likely that a combination of improved attention to dietary and environmental factors, along with advances in gene therapy and protein targeted drugs, will have virtually eliminated most major classes of disease.
From an economic standpoint, the best news may be that these accomplishments could be accompanied by a drop in health-care costs. (62) Costs may even fall as diseases are brought under control using pinpointed, short term therapies now being developed. By 2050 there will be fewer hospitals, and surgical procedures will be largely restricted to the treat ment of accidents and other forms of trauma(外伤). Spending on nonacute(慢性病的) care, both in nursing facilities and in homes, will also fall sharply as more elderly people lead healthy lives until close to death.
One result of medicine’s success in controlling disease will be a dramatic increase in life expectancy. (63) The extent of that increase is a highly speculative matter, but it is worth noting that medical science has already helped to make the very old (currently defined as those over 85 years of age) the fastest growing segment of the population. Between 1960 and 1995, the U.S. population as a whole increased by about 45%, while the segment over 85 years of age grew by almost 300%. () There has been a similar explosion in the population of centenarians, with the result that survival to the age of 100 is no longer the newsworthy feat that it was only a few decades ago. U.S. Census Bureau projections already forecast dramatic increase in the number of centenarians in the next 50 years: 4 million in 2050, compared with 37,000 in 1990.
(65) Although Census Bureau calculations project an increase in average life span of only eight years by the year 2050, some experts believe that the human life span should not begin to encounter any theoretical natural limits before 120 years.With continuing advances in molecular medicine and a growing understanding of the aging process, that limit could rise to 130 years or more.

手机使用
分享
复制链接
新浪微博
分享QQ
微信扫一扫
微信内点击右上角“…”即可分享
反馈
收藏 - 刷刷题收藏
举报
参考答案:
举一反三

【多选题】( )是造成多种慢性病的三大行为危险因素。

A.
吸烟
B.
饮酒
C.
喝茶
D.
身体活动不足
E.
膳食不合理

【单选题】采用化学治疗后早期渗出性病变()

A.
吸收愈合十分缓慢
B.
可完全吸收或仅留少许纤维条索
C.
常发生液化或形成空洞引起新病灶
D.
病变逐渐吸收缩小或形成钙化
E.
关系相当复杂/尚不十分清楚

【单选题】(2009)ARDS共同性病理变化有

A.
气道阻塞
B.
肺部感染
C.
肺不张
D.
急性心力衰竭
E.
肺血管内皮和肺泡损害,肺间质水肿

【单选题】易误诊为良性病变的骨肉瘤为:()

A.
血管扩张型骨肉瘤
B.
纤维组织细胞型骨肉瘤
C.
骨膜骨肉瘤
D.
髓内高分化骨肉瘤

【单选题】老年人常见慢性病病因包括:( )

A.
缺少运动、肥胖
B.
高血压
C.
以上都是
D.
高血脂
相关题目:
【多选题】( )是造成多种慢性病的三大行为危险因素。
A.
吸烟
B.
饮酒
C.
喝茶
D.
身体活动不足
E.
膳食不合理
【单选题】采用化学治疗后早期渗出性病变()
A.
吸收愈合十分缓慢
B.
可完全吸收或仅留少许纤维条索
C.
常发生液化或形成空洞引起新病灶
D.
病变逐渐吸收缩小或形成钙化
E.
关系相当复杂/尚不十分清楚
【单选题】(2009)ARDS共同性病理变化有
A.
气道阻塞
B.
肺部感染
C.
肺不张
D.
急性心力衰竭
E.
肺血管内皮和肺泡损害,肺间质水肿
【单选题】易误诊为良性病变的骨肉瘤为:()
A.
血管扩张型骨肉瘤
B.
纤维组织细胞型骨肉瘤
C.
骨膜骨肉瘤
D.
髓内高分化骨肉瘤
【单选题】老年人常见慢性病病因包括:( )
A.
缺少运动、肥胖
B.
高血压
C.
以上都是
D.
高血脂
【单选题】适于治疗首发急性病人和慢性病人的药物是( )。
A.
舒必利
B.
丙米嗪
C.
碳酸锂
D.
利培酮
E.
五氟利多
刷刷题-刷题-导入试题 - 刷刷题
参考解析:
AI解析
重新生成
题目纠错 0
发布
刷刷题-刷题-导入试题 - 刷刷题刷刷题-刷题-导入试题 - 刷刷题刷刷题-刷题-导入试题 - 刷刷题
刷刷题-刷题-导入试题 - 刷刷题
刷刷题-刷题-导入试题 - 刷刷题
刷刷题-单词鸭